03/08/2026
Recently, our team had the privilege of visiting the Hudson Institute of Medical Research to meet some of the incredible researchers and scientists dedicated to improving health outcomes for women.
We were inspired to learn about pioneering research for pelvic organ prolapse, a condition affecting 1 in 4 women. Following the challenges and, in some cases, devastating consequences associated with mesh-based implants, researchers are now exploring innovative technologies, including 3D printing, nanotechnology and cellular bioprinting, to develop safer, more effective treatments for women requiring pelvic reconstructive surgery.
We also had the opportunity to hear from Dr Maree Bilandzic and her team about their groundbreaking ovarian cancer research. Ovarian cancer is one of the deadliest cancers affecting women, with around 1,500 Australian women diagnosed each year and only 48% surviving beyond five years. Despite this, treatment has changed very little in the past 30 years, there are more than 30 different subtypes, and there is currently no effective early detection test. The team's research into a novel antibody therapy is now progressing towards first-in-human clinical trials, offering real hope for women diagnosed with this devastating disease.
Earlier this year, we were proud to support this important work through our Bake Sale fundraiser, raising funds for the Hudson Institute's ovarian cancer research.
A heartfelt thank you to Connie and the entire Hudson Institute team for welcoming us and providing such an inspiring tour of your facilities. We look forward to continuing to work together to support research, raise awareness and improve outcomes for women.
Together, research, collaboration and advocacy can change lives.